Drug­mak­ers tout lim­its of IRA im­pact ahead of next ne­go­ti­a­tion round

John­son & John­son, As­traZeneca and Pfiz­er lead­ers re­it­er­at­ed dur­ing the JP Mor­gan Health­care Con­fer­ence that the fed­er­al gov­ern­ment’s price ne­go­ti­a­tions still won’t have a ma­te­r­i­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER